RetractedArticleNaunyn-Schmiedeberg's archives of pharmacology2019

Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1.

Qian Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.